Karolinska Institutet study links NOACs to slower Alzheimer's cognitive decline
2 Sep 18 · 5d ago · 2 articles · 2 sources · development 2 of 2
Swedish researchers published findings in the European Heart Journal showing that people with both atrial fibrillation and Alzheimer's disease who took NOAC blood thinners showed significantly slower cognitive decline (>0.2 MMSE points annually) compared to those on warfarin or no anticoagulant treatment.
“There are reasons to believe that the treatment could have a positive effect on cognition, for example by improving blood flow and reducing small-scale damage in the brain.”
Maria EriksdotterMaria Eriksdotter Lead researcher, Karolinska InstitutetNanbo Zhu Researcher, Karolinska InstitutetKarolinska Institutet Research institution
The whole story articlesposts the bright band is this development · numbered dots are the others · click one to jump
What was reported 1 claim about this development
-
first by sciencedaily.com, 5d ago · also Science Daily
All 2 developments of NOAC blood thinners may slow cognitive decline in… →
NewswiresGoogle NewsMastodon